Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Int J Drug Policy. 2022 Oct 3;109:103853. doi: 10.1016/j.drugpo.2022.103853

Table 4.

Hazard ratios for mortality in persons with opioid-related disorders

Adjusted analyses
Unadjusted analyses Model 1 Model 2 Model 3
HR
(95% CI)
aHR
(95% CI)
aHR
(95% CI)
aHR
(95% CI)
Opioid-related disorders 2.13 (1.72–2.63) 2.28 (1.84–2.82) 1.67 (1.35–2.06)
 Harmful use 2.29 (1.19–4.39) 2.45 (1.27–4.74)
 Dependence or withdrawal 1.60 (1.06–2.41) 2.44 (1.60–3.72)
 Unspecified or other F11 diagnosis 2.38 (1.58–3.59) 1.35 (0.89–2.03)
 Opioid agonist use 2.81 (2.09–3.77) 3.06 (2.26–4.15)

Model 1 adjusted for year, age, sex, medical insurance coverage, and population group. Model 2 adjusted for year, age, sex, medical insurance coverage, population group and co-morbid mental health and substance use disorder. Model 3 included binary exposure variables for ICD-10 diagnoses for harmful opioid use (F11.1), dependence or withdrawal (F11.2–4), unspecified or other opioid-related disorders (F11.0, F11.5–9) and a binary exposure variable for opioid agonist use and was adjusted for year, age, sex, medical insurance coverage, and population group.